Not applicableNot Yet RecruitingNCT07446218What this trial is testingPharmacist-led Interventions in Psychiatric PatientsWho this might be right forMental DisordersMetabolic Syndrome University of Lahore 148
Large-scale testing (Phase 3)Active Not RecruitingNCT04285086What this trial is testingRopeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or IntoleranceWho this might be right forEssential Thrombocythemia PharmaEssentia 174
Very early researchEnded earlyNCT02724202What this trial is testingCurcumin in Combination With 5FU for Colon CancerWho this might be right forMetastatic Colon Cancer Baylor Research Institute 15
Testing effectiveness (Phase 2)Looking for participantsNCT05720130What this trial is testingPhase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).Who this might be right forProstate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer AdvanCell Pty Limited 100
Testing effectiveness (Phase 2)Looking for participantsNCT06463665What this trial is testingEfficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerWho this might be right forAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more Genelux Corporation 142
Large-scale testing (Phase 3)Not Yet RecruitingNCT07795268What this trial is testingStudy to Evaluate the Efficacy and Safety of 177Lu-NYM032 Injection in Participants With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)Who this might be right forProstate Cancer Norroy Bioscience Co., LTD 600
Not applicableStudy completedNCT01812668What this trial is testingCabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate CancerWho this might be right forAdenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00630552What this trial is testingQUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerWho this might be right forAdenocarcinoma of the PancreasMetastatic Pancreatic CancerPancreatic Cancer NantCell, Inc. 138
Early research (Phase 1)Study completedNCT01218256What this trial is testingSecondary Prevention in Type 2 Diabetes: Comparison of Two Different Resistance Exercise Training ProtocolsWho this might be right forType 2 Diabetes Mellitus Paracelsus Medical University 32
Early research (Phase 1)Study completedNCT04666129What this trial is testingStudy of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate CancerMetastatic Castration-Sensitive Prostate CancerNon-Metastatic Castration-Resistant Prostate Cancer Sumitomo Pharma America, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07354594What this trial is testingExternal Beam and Radioligand Radiotherapy for mCRPCWho this might be right forProstate Cancer Metastatic Castration-Resistant Centre hospitalier de l'Université de Montréal (CHUM) 120
Early research (Phase 1)Study completedNCT05022849What this trial is testingJNJ-75229414 for Metastatic Castration-resistant Prostate Cancer ParticipantsWho this might be right forProstatic Neoplasms Janssen Research & Development, LLC 15
Testing effectiveness (Phase 2)Study completedNCT00942578What this trial is testingTrial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate CancerWho this might be right forMetastatic Prostate Cancer National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT06702618What this trial is testingEvaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast CancerWho this might be right forBreast Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33
Not applicableUnknownNCT05116579What this trial is testingCirculating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)Who this might be right forMetastatic Castration-resistant Prostate Cancer Sun Yat-sen University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07706179What this trial is testingTargeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast CancerWho this might be right forHR+/HER2+ Breast CancerMetastatic Breast Cancer University of Wisconsin, Madison 10
Not applicableStudy completedNCT00899496What this trial is testingLaboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy ParticipantsWho this might be right forCancer Wake Forest University Health Sciences 54
Not applicableStudy completedNCT04118062What this trial is testingCommunicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)Who this might be right forMetastatic Uveal MelanomaTriple Negative Breast CancerLuminal B Breast Cancer+1 more Institut Curie 128
Not applicableWithdrawnNCT00700362What this trial is testingInsulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)Who this might be right forDiabetes MellitusInsulin ResistanceHyperglycemia+1 more Karolinska Institutet
Testing effectiveness (Phase 2)Looking for participantsNCT07198724What this trial is testingERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast CancerWho this might be right forMetastatic Breast CancerHER2 Low Breast CarcinomaHER2-negative Breast Cancer+2 more Kristina A. Fanucci 65